The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...

The Centers for Disease Control and Prevention's vaccine advisory committee is set to meet for the first time since Health ...

Beyfortus, developed by the British-Swedish drugmaker AstraZeneca in partnership with the French pharmaceutical company Sanofi, was introduced in 2023 as game changing for infants since only one ...

The green light in the US is the first worldwide for Enflonsia (clesrovimab) and makes the long-acting antibody the first competitor to Sanofi and AstraZeneca's blockbuster Beyfortus (nirsevimab ...

Sanofi and AstraZeneca are closing in on EU approval of nirsevimab, their long-acting antibody for the protection of newborns and infants from respiratory syncytial virus (RSV) infections. The EMA ...

The Centers for Disease Control and Prevention's vaccine advisory committee is set to meet for the first time since Health ...

In a move that has left many public health observers reeling, a newly appointed vaccine committee under Health and Human Services Secretary Robert F. Kennedy Jr. has voted to recommend an RSV shot for ...

The latest international AstraZeneca PLC news and views from Reuters - one of the world's largest news agencies ...

Find the latest AstraZeneca PLC (AZN.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.